查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595412

肺炎链球菌检测市场：按方法、技术、产品类型和最终用户划分 - 2025-2030 年全球预测

Pneumococcal Testing Market by Method (Immunodiagnostics, Molecular Diagnostic, Point of Care Testing), Technology (Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry), Product Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肺炎球菌检测市场价值为16.6亿美元，预计到2024年将达到18亿美元，复合年增长率为8.99%，预计到2030年将达到30.3亿美元。

肺炎球菌检测包括多种旨在检测肺炎球菌引起的感染疾病的诊断方法。肺炎球菌是一种在世界各地引起显着发病率和死亡率的细菌，特别是在幼儿和老年人中。肺炎球菌检测的需求源自于需要及时、准确的检测，以帮助做出适当的治疗决策，从而减少併发症并改善公共卫生结果。肺炎球菌检测主要在临床环境、医院和诊断实验室进行，快速诊断有助于加快治疗速度、为疫苗策略提供资讯并监测抗生素抗药性菌株的传播。主要最终使用者包括医疗保健提供者、政府机构和研究机构。根据市场洞察，显着增长是由肺炎和败血症发病率上升、诊断技术的技术进步以及全球意识和医疗基础设施投资的提高所推动的。就地检验和即时PCR的出现透过提供高精度和快速结果推动了市场扩张。疾病流行率高且诊断服务匮乏的新兴市场蕴藏大量商机。透过经济高效、易于使用的测试解决方案进入这些市场可以显着增加市场占有率。然而，先进诊断技术的高成本、监管挑战以及欠发达地区缺乏认识等因素限制了市场成长。技术壁垒和对技能人才的需求也是挑战。创新领域在于开发具有成本效益、快速且多重的诊断测试，以及提高预防感染的疫苗血清型覆盖率。生物技术公司和政府卫生机构在研究经费和政策制定方面的合作可望扩大市场。市场竞争激烈，需要不断的研究和创新来区分产品并有效满足不断变化的医疗保健需求。

主要市场统计
基准年[2023] 16.6亿美元
预测年份 [2024] 18亿美元
预测年份 [2030] 30.3亿美元
复合年增长率（%） 8.99%

市场动态：快速发展的肺炎球菌检测市场的关键市场洞察

供需的动态交互作用正在改变肺炎球菌检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 随着早期诊断和治疗的改善，肺炎球菌检测的采用率提高
    • 肺炎链球菌疾病的盛行率迅速增加
    • 正在进行的疫苗和药物分子开发临床试验
  • 市场限制因素
    • 开发肺炎球菌检测方法的高成本
  • 市场机会
    • POC 测试日益普及
    • 增加研发投入并推动体外诊断（IVD）检测技术
  • 市场挑战
    • 缺乏专家

波特五力：驾驭肺炎链球菌检测市场的策略工具

波特的「五力」框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肺炎链球菌检测市场的外部影响

外部宏观环境因素在塑造肺炎球菌检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解肺炎链球菌检测市场的竞争状况

对肺炎球菌测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵肺炎链球菌检测市场供应商的绩效评估

FPNV定位矩阵是评估肺炎链球菌检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了肺炎球菌检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，肺炎球菌检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于早期诊断和治疗的改善，肺炎球菌检测的采用率有所提高
      • 肺炎链球菌感染人数迅速增加
      • 疫苗和药物分子开发的临床试验正在进行中
    • 抑制因素
      • 开发肺炎球菌检测方法的高成本
    • 机会
      • POC 测试日益普及
      • 加大研发投入，体外诊断（IVD）检测技术取得进展
    • 任务
      • 缺乏专家
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 肺炎链球菌检测市场：依方法分类

  • 免疫诊断
  • 分子诊断
  • 就地检验

第七章肺炎链球菌检测市场：依技术分类

  • 酵素免疫分析法
  • 萤光
  • 免疫组织化学
  • 基于核酸序列的扩增
  • 聚合酵素链锁反应
  • 西方墨点法试验

第八章肺炎链球菌检测市场：依产品类型

  • 分析仪
  • 消耗品

第九章肺炎链球菌检测市场：依最终用户分类

  • 门诊手术中心
  • 医院/诊所

第十章 北美及南美肺炎链球菌检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太肺炎链球菌检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的肺炎球菌检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Acon Labs Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cepheid Inc.
  • F-Hoffmann la Roche Ltd.
  • Hologic, Inc.
  • Meridian Bioscience, Inc. by SD Biosensor
  • Novartis AG
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
Product Code: MRR-4103B31E098A

The Pneumococcal Testing Market was valued at USD 1.66 billion in 2023, expected to reach USD 1.80 billion in 2024, and is projected to grow at a CAGR of 8.99%, to USD 3.03 billion by 2030.

Pneumococcal testing encompasses a range of diagnostic methods aimed at detecting infections caused by Streptococcus pneumoniae, a bacterium responsible for significant morbidity and mortality worldwide, particularly among young children and the elderly. The necessity of pneumococcal testing stems from the need for timely and accurate detection that aids in appropriate treatment decisions, thereby reducing complications and improving public health outcomes. Applications of pneumococcal testing are predominantly seen in clinical settings, hospitals, and diagnostic laboratories where rapid diagnosis can expedite treatment, inform vaccination strategies, and help monitor the spread of antibiotic-resistant strains. Key end-users include healthcare providers, government entities, and research institutions. Market insights reveal significant growth influenced by rising incidences of pneumonia and sepsis, technological advancements in diagnostic techniques, and increased awareness and investment in healthcare infrastructure globally. The advent of point-of-care testing and real-time PCR is driving market expansion by offering high accuracy and swift results. Opportunities abound in emerging markets where the prevalence of disease is high but diagnostic services are underserved. Penetrating these markets with cost-effective and easy-to-use testing solutions can markedly expand market share. However, market growth faces limitations such as the high cost of advanced diagnostic technologies, regulatory challenges, and a lack of awareness in underdeveloped regions. Technological barriers and the need for skilled personnel further pose challenges. Areas of innovation lie in the development of cost-effective, rapid, and multiplexed diagnostic tests, as well as enhanced vaccine serotype coverage to preempt infection. Collaboration between biotech companies and governmental health bodies for research funding and policy making is promising for market expansion. The nature of the market is highly competitive, encouraging continuous research and innovation for companies to differentiate their products and meet evolving healthcare demands effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 1.66 billion
Estimated Year [2024] USD 1.80 billion
Forecast Year [2030] USD 3.03 billion
CAGR (%) 8.99%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pneumococcal Testing Market

The Pneumococcal Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of pneumococcal testing with improvement in early diagnosis and treatment
    • Upsurge in the number of prevalence of pneumococcal disease
    • Ongoing clinical trials for development of vaccines and drug molecules
  • Market Restraints
    • High cost associated with the development of pneumococcal testing methods
  • Market Opportunities
    • Rising popularity for POC tests
    • Increasing R&D investments and advancements in testing technologies for in-vitro diagnostic (IVD)
  • Market Challenges
    • Dearth of professionals

Porter's Five Forces: A Strategic Tool for Navigating the Pneumococcal Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pneumococcal Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pneumococcal Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pneumococcal Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pneumococcal Testing Market

A detailed market share analysis in the Pneumococcal Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pneumococcal Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pneumococcal Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pneumococcal Testing Market

A strategic analysis of the Pneumococcal Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pneumococcal Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acon Labs Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Cepheid Inc., F-Hoffmann la Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc. by SD Biosensor, Novartis AG, Pfizer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Pneumococcal Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostic, and Point of Care Testing.
  • Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Nucleic Acid Sequence Based Amplification, Polymerase Chain Reaction, and Western Blot Test.
  • Based on Product Type, market is studied across Analyzers and Consumables.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of pneumococcal testing with improvement in early diagnosis and treatment
      • 5.1.1.2. Upsurge in the number of prevalence of pneumococcal disease
      • 5.1.1.3. Ongoing clinical trials for development of vaccines and drug molecules
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of pneumococcal testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising popularity for POC tests
      • 5.1.3.2. Increasing R&D investments and advancements in testing technologies for in-vitro diagnostic (IVD)
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pneumococcal Testing Market, by Method

  • 6.1. Introduction
  • 6.2. Immunodiagnostics
  • 6.3. Molecular Diagnostic
  • 6.4. Point of Care Testing

7. Pneumococcal Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme Linked Immunosorbent Assay
  • 7.3. Immunofluorescence
  • 7.4. Immunohistochemistry
  • 7.5. Nucleic Acid Sequence Based Amplification
  • 7.6. Polymerase Chain Reaction
  • 7.7. Western Blot Test

8. Pneumococcal Testing Market, by Product Type

  • 8.1. Introduction
  • 8.2. Analyzers
  • 8.3. Consumables

9. Pneumococcal Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals & Clinics

10. Americas Pneumococcal Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pneumococcal Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pneumococcal Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acon Labs Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux S.A.
  • 6. Cepheid Inc.
  • 7. F-Hoffmann la Roche Ltd.
  • 8. Hologic, Inc.
  • 9. Meridian Bioscience, Inc. by SD Biosensor
  • 10. Novartis AG
  • 11. Pfizer Inc.
  • 12. Qiagen N.V.
  • 13. Quest Diagnostics Incorporated
  • 14. Thermo Fisher Scientific Inc.
  • 15. Trinity Biotech PLC

LIST OF FIGURES

  • FIGURE 1. PNEUMOCOCCAL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PNEUMOCOCCAL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PNEUMOCOCCAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PNEUMOCOCCAL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY WESTERN BLOT TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023